Patrick J Bolan1, Eunhee Kim2,3, Benjamin A Herman3,4, Gillian M Newstead5, Mark A Rosen6, Mitchell D Schnall3,6, Etta D Pisano7, Paul T Weatherall8, Elizabeth A Morris9, Constance D Lehman10, Michael Garwood1, Michael T Nelson1, Douglas Yee11, Sandra M Polin12, Laura J Esserman13, Constantine A Gatsonis3,4, Gregory J Metzger1, David C Newitt14, Savannah C Partridge15, Nola M Hylton14. 1. Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA. 2. National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA. 3. American College of Radiology Imaging Network (ACRIN), Philadelphia, Pennsylvania, USA. 4. Center for Statistical Sciences, Brown University, Providence, Rhode Island, USA. 5. Department of Radiology, University of Chicago, Chicago, Illinois, USA. 6. Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. 7. Department of Radiology, Medical College of South Carolina, Charleston, South Carolina, USA. 8. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 9. Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. 10. Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. 11. Masonic Cancer Center and Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. 12. Washington Radiology Associates, P.C., Fairfax, Virginia, USA. 13. Department of Surgery, University of California, San Francisco, California, USA. 14. Department of Radiology, University of California, San Francisco, California, USA. 15. Department of Radiology, University of Washington, Seattle, Washington, USA.
Abstract
PURPOSE: To estimate the accuracy of predicting response to neoadjuvant chemotherapy (NACT) in patients with locally advanced breast cancer using MR spectroscopy (MRS) measurements made very early in treatment. MATERIALS AND METHODS: This prospective Health Insurance Portability and Accountability Act (HIPAA)-compliant protocol was approved by the American College of Radiology and local-site institutional review boards. One hundred nineteen women with invasive breast cancer of ≥3 cm undergoing NACT were enrolled between September 2007 and April 2010. MRS measurements of the concentration of choline-containing compounds ([tCho]) were performed before the first chemotherapy regimen (time point 1, TP1) and 20-96 h after the first cycle of treatment (TP2). The change in [tCho] was assessed for its ability to predict pathologic complete response (pCR) and radiologic response using the area under the receiver operating characteristic curve (AUC) and logistic regression models. RESULTS: Of the 119 subjects enrolled, only 29 cases (24%) with eight pCRs provided usable data for the primary analysis. Technical challenges in acquiring quantitative MRS data in a multi-site trial setting limited the capture of usable data. In this limited data set, the decrease in tCho from TP1 to TP2 had poor ability to predict either pCR (AUC = 0.53, 95% confidence interval [CI]: 0.27-0.79) or radiologic response (AUC = 0.51, 95% CI: 0.27-0.75). CONCLUSION: The technical difficulty of acquiring quantitative MRS data in a multi-site clinical trial setting led to a low yield of analyzable data, which was insufficient to accurately measure the ability of early MRS measurements to predict response to NACT. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:290-302.
PURPOSE: To estimate the accuracy of predicting response to neoadjuvant chemotherapy (NACT) in patients with locally advanced breast cancer using MR spectroscopy (MRS) measurements made very early in treatment. MATERIALS AND METHODS: This prospective Health Insurance Portability and Accountability Act (HIPAA)-compliant protocol was approved by the American College of Radiology and local-site institutional review boards. One hundred nineteen women with invasive breast cancer of ≥3 cm undergoing NACT were enrolled between September 2007 and April 2010. MRS measurements of the concentration of choline-containing compounds ([tCho]) were performed before the first chemotherapy regimen (time point 1, TP1) and 20-96 h after the first cycle of treatment (TP2). The change in [tCho] was assessed for its ability to predict pathologic complete response (pCR) and radiologic response using the area under the receiver operating characteristic curve (AUC) and logistic regression models. RESULTS: Of the 119 subjects enrolled, only 29 cases (24%) with eight pCRs provided usable data for the primary analysis. Technical challenges in acquiring quantitative MRS data in a multi-site trial setting limited the capture of usable data. In this limited data set, the decrease in tCho from TP1 to TP2 had poor ability to predict either pCR (AUC = 0.53, 95% confidence interval [CI]: 0.27-0.79) or radiologic response (AUC = 0.51, 95% CI: 0.27-0.75). CONCLUSION: The technical difficulty of acquiring quantitative MRS data in a multi-site clinical trial setting led to a low yield of analyzable data, which was insufficient to accurately measure the ability of early MRS measurements to predict response to NACT. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:290-302.
Authors: K A Kvistad; I J Bakken; I S Gribbestad; B Ehrnholm; S Lundgren; H E Fjøsne; O Haraldseth Journal: J Magn Reson Imaging Date: 1999-08 Impact factor: 4.813
Authors: Sina Meisamy; Patrick J Bolan; Eva H Baker; Robin L Bliss; Evin Gulbahce; Lenore I Everson; Michael T Nelson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood Journal: Radiology Date: 2004-11 Impact factor: 11.105
Authors: Paul E Sijens; Monique D Dorrius; Peter Kappert; Paul Baron; Ruud M Pijnappel; Matthijs Oudkerk Journal: Magn Reson Imaging Date: 2010-01-13 Impact factor: 2.546
Authors: Mark Mikkelsen; Peter B Barker; Pallab K Bhattacharyya; Maiken K Brix; Pieter F Buur; Kim M Cecil; Kimberly L Chan; David Y-T Chen; Alexander R Craven; Koen Cuypers; Michael Dacko; Niall W Duncan; Ulrike Dydak; David A Edmondson; Gabriele Ende; Lars Ersland; Fei Gao; Ian Greenhouse; Ashley D Harris; Naying He; Stefanie Heba; Nigel Hoggard; Tun-Wei Hsu; Jacobus F A Jansen; Alayar Kangarlu; Thomas Lange; R Marc Lebel; Yan Li; Chien-Yuan E Lin; Jy-Kang Liou; Jiing-Feng Lirng; Feng Liu; Ruoyun Ma; Celine Maes; Marta Moreno-Ortega; Scott O Murray; Sean Noah; Ralph Noeske; Michael D Noseworthy; Georg Oeltzschner; James J Prisciandaro; Nicolaas A J Puts; Timothy P L Roberts; Markus Sack; Napapon Sailasuta; Muhammad G Saleh; Michael-Paul Schallmo; Nicholas Simard; Stephan P Swinnen; Martin Tegenthoff; Peter Truong; Guangbin Wang; Iain D Wilkinson; Hans-Jörg Wittsack; Hongmin Xu; Fuhua Yan; Chencheng Zhang; Vadim Zipunnikov; Helge J Zöllner; Richard A E Edden Journal: Neuroimage Date: 2017-07-14 Impact factor: 6.556
Authors: Ioannis Tsougos; Alexandros Vamvakas; Constantin Kappas; Ioannis Fezoulidis; Katerina Vassiou Journal: Comput Math Methods Med Date: 2018-09-23 Impact factor: 2.238